Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,960.00    2.00 (0.05%)
Bid:
3,926.00
Ask:
3,930.00
Spread: 4.00 (0.102%)
Market Cap: £14.96b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Directorate Change

15 Nov 2021 07:00

RNS Number : 2772S
Halma PLC
15 November 2021
 

Halma plc ("Halma")

 

Appointment of independent non-executive Director

Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Sharmila Nebhrajani OBE as an independent non-executive Director, effective 1 December 2021. Sharmila will also be a member of Halma's Audit, Remuneration and Nomination Committees.

 

Sharmila brings a wealth of experience gained across a variety of roles - spanning both the public and private/NGO sectors - with a particularly strong background in sustainability and health. She is currently a non-executive director at ITV plc and Severn Trent plc, and Chair of the National Institute for Health and Care Excellence (NICE).Sharmila was Chief Executive of Wilton Park (part of the Foreign and Commonwealth Office), responsible for convening international policy dialogue with governments, NGOs, policy makers and academics on topics such as global health and climate risk. Previously, she worked for the Medical Research Council, Association of Medical Research Charities and NHS Sussex. In her earlier career, she held senior positions within the BBC, Cable & Wireless plc and PwC.

Dame Louise Makin, Chair, commented: "I am delighted that Sharmila has agreed to join the Halma Board. Her diverse experience, particularly in the health and medical sector, will undoubtedly bring a fresh perspective and valuable insights to the Board."

 

There are no further details to be disclosed for Sharmila Nebhrajani under Listing Rule 9.6.13R.

 

For further information, please contact:

 

Halma plc

Andrew Williams, Group Chief Executive

+44 (0)1494 721111

Marc Ronchetti, Chief Financial Officer

Charles King, Head of Investor Relations

+44 (0)7776 685948

Clayton Hirst, Director of Corporate Affairs

+44 (0)7384 796013

 

MHP Communications

Andrew Jaques / Rachel Farrington

+44 (0)20 3128 8788

 

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

Notes

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day.

Its purpose defines the three broad market areas where it operates:

· Safety: protecting life as populations grow and protecting worker safety.

· Environment: improving food and water quality, and monitoring air pollution.

· Health: meeting rising healthcare demand as growing populations age and lifestyles change.

It employs over 7,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

In January 2021, Halma was named Britain's Most Admired Company by Management Today.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADZMMMDZVGMZM
Date   Source Headline
2nd May 200810:47 amRNSTotal Voting Rights
25th Apr 200812:21 pmRNSHolding(s) in Company
3rd Apr 20083:22 pmRNSDirectorate Change
1st Apr 20084:11 pmRNSDirector/PDMR Shareholding
1st Apr 20083:34 pmRNSTotal Voting Rights
28th Mar 20084:04 pmRNSTreasury Stock
27th Mar 20089:47 amRNSHolding(s) in Company
25th Mar 20086:07 pmRNSDirector/PDMR Shareholding
14th Mar 200811:42 amRNSDirector/PDMR Shareholding
3rd Mar 20084:19 pmRNSTotal Voting Rights
29th Feb 20084:40 pmRNSHolding(s) in Company
19th Feb 20082:46 pmRNSHolding(s) in Company
18th Feb 200811:45 amRNSHolding(s) in Company
18th Feb 20089:59 amRNSTreasury Stock
14th Feb 20087:00 amRNSInterim Management Statement
5th Feb 20081:08 pmRNSHolding(s) in Company
1st Feb 20083:17 pmRNSBlocklisting Interim Review
1st Feb 20083:15 pmRNSTotal Voting Rights
9th Jan 20083:59 pmRNSTreasury Stock
8th Jan 200811:12 amRNSHolding(s) in Company
4th Jan 20081:06 pmRNSHolding(s) in Company
2nd Jan 20084:47 pmRNSTotal Voting Rights
21st Dec 200711:25 amRNSDirector Declaration
20th Dec 20077:00 amRNSAcquisition
4th Dec 20073:09 pmRNSDirector/PDMR Shareholding
4th Dec 200711:50 amRNSTotal Voting Rights
29th Nov 200711:23 amRNSDoc re. Half year report 2007
29th Nov 20077:00 amRNSInterim Results
16th Nov 20074:18 pmRNSNotice of Results
6th Nov 20071:03 pmRNSHolding(s) in Company
2nd Nov 200711:48 amRNSTotal Voting Rights
25th Oct 20077:00 amRNSPost-Close Trading Update
5th Oct 20074:02 pmRNSTreasury Stock
1st Oct 200710:00 amRNSTotal Voting Rights
27th Sep 200710:22 amRNSTreasury Stock
19th Sep 20079:38 amRNSDirector/PDMR Shareholding
3rd Sep 20073:08 pmRNSTotal Voting Rights
7th Aug 20075:35 pmRNSTreasury Stock
3rd Aug 20075:33 pmRNSDoc re. AGM 2007 Resolutions
3rd Aug 20074:15 pmRNSHolding(s) in Company
2nd Aug 200711:34 amRNSDirectorate Change
1st Aug 20077:00 amRNSInterim Management Statement
31st Jul 200710:22 amRNSTotal Voting Rights
30th Jul 200712:40 pmRNSHolding(s) in Company
27th Jul 20074:46 pmRNSHolding(s) in Company
26th Jul 200711:36 amRNSAnnual Information Update
20th Jul 200712:39 pmRNSBlocklisting Interim Review
11th Jul 20073:13 pmRNSHolding(s) in Company
10th Jul 20072:15 pmRNSHolding(s) in Company
9th Jul 200712:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.